With 9.2% CAGR, Protein Detection & Quantification Market to Hit US$ 4.4 Billion by 2028 | IMARC Group

According to the latest report by IMARC Group, titled "Protein Detection & Quantification Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," The global protein detection & quantification market size reached US$ 2.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.4 Billion by 2028, exhibiting a growth rate (CAGR) of 9.2% during 2023-2028.

Protein detection and quantification represent methods that are generally used by scientific experts to determine the total protein content and its characteristics. It aids in developing a comparison between two distinctive protein samples, measuring enzyme kinetics, verifying the success of the lysis step, etc. In line with this, some of the commonly utilized protein detection and quantification techniques include enzyme-linked immunosorbent assay (ELISA), mass spectrometry, western blot analysis, nanoparticles, nanopore-based methods, etc. Consequently, they are extensively used across academic institutions, research organizations, biotechnology and pharmaceutical companies, etc., for clinical diagnosis and research studies.

Request for a free sample copy of this report: https://www.imarcgroup.com/protein-detection-quantification-market/requestsample 

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Market Trends                                           

The rising technological advancements in biotechnology are primarily augmenting the protein detection and quantification market. Furthermore, the widespread adoption of infrared spectroscopy and immunoassay techniques that help experts in attaining accurate results is positively influencing the global market. Apart from this, the elevating investments by private and public agencies to conduct extensive R&D activities in the field of proteomics are acting as significant growth-inducing factors. Moreover, the increasing prevalence of chronic diseases, including cancer, is propelling the need for diagnosing them at a molecular level to develop therapeutic treatments, which is also bolstering the market growth. Besides this, the expanding genomics sector, the growing number of research laboratories and clinical trials, and continuous improvements to upgrade the existing healthcare infrastructures are further catalyzing the global market. Additionally, the escalating demand for advanced instruments, along with the sudden outbreak of the COVID-19 pandemic across countries, is expected to fuel the protein detection and quantification market in the coming years.

Breakup by Product Type:

Kits and Reagents/Consumables
Instruments
Services

Breakup by Technology:

Colorimetric Assays
Immunological Methods
Chromatography
Mass Spectrometry
Spectroscopy Instruments
Others

Breakup by Application:

Drug Discovery and Development
Clinical Diagnosis
Others

Breakup by End User:

Academic Research Institutes
Biotechnology and Pharmaceutical Companies
Contract Research Organization
Others

Breakup by Region:

North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa

Competitive Landscape with Key Player:

Agilent Technologies Inc
Bio-Rad Laboratories Inc
Danaher Corporation
General Electric Company
Inanovate Inc
Merck KGaA
PerkinElmer Inc
RayBiotech Life Inc
Shimadzu Corporation
Thermo Fisher Scientific Inc

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/protein-detection-quantification-market

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

If you want latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Other Report by IMARC Group:

Latin America Telehealth Market Report: https://www.imarcgroup.com/latin-america-telehealth-market

India Organ Preservation Market Report: https://www.imarcgroup.com/india-organ-preservation-market

Europe Organ Preservation Market Report: https://www.imarcgroup.com/europe-organ-preservation-market

Latin America Generic Injectables Market Report: https://www.imarcgroup.com/latin-america-generic-injectables-market

India Generic Injectables Market Report: https://www.imarcgroup.com/india-generic-injectables-market

United States Transfection Technologies Market Report: https://www.imarcgroup.com/united-states-transfection-technologies-market

Veterinary Infectious Disease Diagnostics Market Report: https://www.imarcgroup.com/veterinary-infectious-disease-diagnostics-market

Premenstrual Syndrome Treatment Market Report: https://www.imarcgroup.com/premenstrual-syndrome-treatment-market

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.